TETANUS Antibody Detection in Saliva Study

Starting soon · Not applicable

Conditions studied: Tetanus

In brief

This study aims to design, develop and optimise a non-invasive, saliva sample-based point-of-care lateral flow test for use in low and middle income settings that can return a qualitative result on whether an individual has or has not immunity to tetanus within 10-15mins. If successful, this approach would not require blood sampling or laboratory facilities, empower personalised decision making on vaccine needs and support the development of population level data-driven public health policies.

Key facts

Study ID
NCT07446166
Run by
University of Birmingham
People needed
390
Starts
2026-02-01
Expected to finish
2028-02-01
Last updated by the study team
2026-03-03

Who can join

Age: 5 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.